MedPath

Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)

Not Applicable
Conditions
COPD
Interventions
Device: Spirotiger®
Registration Number
NCT01218295
Lead Sponsor
Università degli Studi di Ferrara
Brief Summary

Many studies suggest that inspiratory muscles training by means of normocapnic hyperpnea improves exercise tolerance in healthy subjects. No information is available about the use of this training in COPD patients even if other methods (such as threshold loading and resistive loading) have been shown to be effective in terms of Inspiratory Muscle Function, Health-Related Quality of Life and Exercise Tolerance.

This study is designed to evaluate the effects of normocapnic hyperventilation by means of Spirotiger®, an instrument training the respiratory muscles, avoiding hypocapnia (using the methodology of isocapnic hyperpnoea)in COPD patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • COPD patients. All patients are at stable state, free from an exacerbation from at least 3 months.
Exclusion Criteria
  • COPD patients with a recent history of cardiovascular disease, neurologic disease and other diseases that would interfere with the training.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Respiratory muscle trainingSpirotiger®Patients assigned to this arm train the respiratory muscles by means of normocapnic hyperpnea.
Primary Outcome Measures
NameTimeMethod
Exercise Capacity1 month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pulmonary Respiratory Unit- University Hospital

🇮🇹

Ferrara, Italy

© Copyright 2025. All Rights Reserved by MedPath